These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9794747)

  • 1. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension.
    Hunter SJ; Harper R; Ennis CN; Crothers E; Sheridan B; Johnston GD; Atkinson AB; Bell PM
    J Hypertens; 1998 Jan; 16(1):103-9. PubMed ID: 9533423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.
    Harper R; Ennis CN; Sheridan B; Atkinson AB; Johnston GD; Bell PM
    BMJ; 1994 Jul; 309(6949):226-30. PubMed ID: 7818648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose bendrofluazide (1.25 mg) effectively lowers blood pressure over 24 h: results of a randomized, double-blind, placebo-controlled crossover study.
    Wiggam MI; Bell PM; Sheridan B; Walmsley A; Atkinson AB
    Am J Hypertens; 1999 May; 12(5):528-31. PubMed ID: 10342793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of antihypertensive treatment on cognitive function: results from the HOPE study.
    Starr JM; Whalley LJ; Deary IJ
    J Am Geriatr Soc; 1996 Apr; 44(4):411-5. PubMed ID: 8636587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J; Nasar MA; Belgrave GP; Walters EG
    Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.
    Harper R; Ennis CN; Heaney AP; Sheridan B; Gormley M; Atkinson AB; Johnston GD; Bell PM
    Diabetologia; 1995 Jul; 38(7):853-9. PubMed ID: 7556989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T; Himmelmann A
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The optimal dose of bendroflumethiazide in hypertension. A randomized double-blind dose-response study].
    Carlsen JE; Køber L; Torp-Pedersen CT; Johansen P
    Ugeskr Laeger; 1990 Oct; 152(42):3072-5. PubMed ID: 2238184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
    Vanmolkot FH; de Hoon JN; van de Ven LL; Van Bortel LM
    J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period.
    Eames PJ; Robinson TG; Panerai RB; Potter JF
    Cerebrovasc Dis; 2005; 19(4):253-9. PubMed ID: 15731556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The systemic haemodynamic and cerebral autoregulatory effects of bendrofluazide in the subacute post-stroke period.
    Eames PJ; Robinson TG; Panerai RB; Potter JF
    J Hypertens; 2004 Oct; 22(10):2017-24. PubMed ID: 15361775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
    Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
    Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.
    Deary AJ; Schumann AL; Murfet H; Haydock SF; Foo RS; Brown MJ
    J Hypertens; 2002 Apr; 20(4):771-7. PubMed ID: 11910315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the acute effects of cicletanine and bendrofluazide on urinary electrolytes and plasma potassium in essential hypertension.
    Singer DR; Markandu ND; Sugden AL; MacGregor GA
    Eur J Clin Pharmacol; 1990; 39(3):227-32. PubMed ID: 2257857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance.
    Girvin B; McDermott BJ; Johnston GD
    J Hypertens; 1999 Nov; 17(11):1627-31. PubMed ID: 10608477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of a 7-day period of non-compliance on blood pressure control using three different antihypertensive agents.
    Girvin BG; Johnston GD
    J Hypertens; 2004 Jul; 22(7):1409-14. PubMed ID: 15201559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N; Lim PO; MacDonald TM
    Circulation; 2001 Jul; 104(5):511-4. PubMed ID: 11479245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.